The Cancer Screening and Prevention Research Group (CSPRG) is an internationally renowned research group based at Imperial College London. Established in 2008 by the late Professor Wendy Atkin, and now headed by Professor Amanda Cross, the group has extensive expertise in conducting clinical trials and includes an experienced team of research scientists, statisticians, clinical trial managers, data analysts and data managers.
What we do
The research focus of the CSPRG is gastrointestinal cancers including bowel cancer, also known as colorectal cancer, oesophageal cancer and gastric cancer. In the UK, over 41,000 people are diagnosed with bowel cancer every year and 16,000 people die from the disease. Through our research we hope to reduce the numbers of people receiving a diagnosis of gastrointestinal cancer and dying from these diseases. Much of our work focuses on how to help make bowel cancer screening and surveillance programmes more effective and acceptable for participants, and more efficient for the NHS and other health services internationally.
How we do it
We conduct large-scale studies by either recruiting people from participating healthcare providers or by collating and analysing data collected from UK hospitals and other health data providers.
Information we may hold about you and your options if you wish to opt out
If you have taken part in a bowel cancer screening programme, gone to your GP with symptoms suggestive of gastrointestinal cancer, agreed to participate in one of our studies, or had bowel cancer treatment on the NHS, we may retain some information about you. Our Protecting your patient data page provides further details on how we process this data and your options if you wish to opt out.